The nation of Zimbabwe has rejected a substantial American health deal valued at $367m (£272m) spanning five years over the United States' request for confidential information.
The decision was revealed after a internal memorandum from December was leaked, revealing that Head of State Emmerson Mnangagwa believed the agreement was "lopsided".
An official spokesperson has since clarified that the United States was requesting health data for scientific study and commercial purposes while refused to share the resulting advantages from future vaccines.
"We are forced to start the difficult and regrettable process of winding down our health assistance in Zimbabwe," said American envoy to Zimbabwe Pamela Tremont publicly.
Her embassy indicated the US had furnished over $1.9bn as health assistance to Zimbabwe over the last two decades.
A medical body in Zimbabwe has called for further dialogue to reach a deal suitable to all parties so the country's critical HIV treatment initiative can be sustained.
Wider Implications
This development comes after a similar case in Kenya, where a court blocked a similar deal with the US following legal challenges were filed about the security of Kenyans' health data.
Since returning to office recently, US President Donald Trump has drastically cut overseas assistance and closed the US Agency for International Development (USAID).
The agency had overseen aid for the US government, but Trump stated its expenditure was "inefficient" and his government was seeking direct bilateral deals to boost openness and accountability.
According to reports, Sixteen African countries have to date signed these new agreements, representing more than $18.3bn in new funding.
Specifics of the Rejected Deal
The money for Zimbabwe would have gone towards "tackling HIV/Aids, TB, malaria, maternal and child health, and preparing for epidemics".
"We believe this partnership would have delivered extraordinary advantages for the people of Zimbabwe, particularly the 1.2 million men, women and children presently receiving antiretroviral therapy via US-supported initiatives," Tremont commented.
However, official spokesman Nick Mangwana argued the arrangement was "unequal".
"Our nation was requested to share its genetic material and health information for a long time, with no corresponding assurance of access to any scientific breakthroughs – such as vaccines, diagnostics, or treatments – that might result from that provided information," Mangwana explained.
"Effectively, our country would provide the raw materials for medical research with no assurance that the resulting innovations would be accessible to our population if a new health crisis arise."
Sovereignty and International Frameworks
He also pointed out that the US's withdrawal from the global health body and its push of bilateral health agreements were upending structures previously set up through the international organization.
The spokesperson gave as an example its Pandemic Benefit-Sharing scheme designed to manage potential pandemics.
"This mechanism is designed to ensure that when a nation contributes its information, the benefits – such as medicines and cures – are distributed fairly, not monopolised exclusively by those with the capability to create them."
These objections over the US deal "should not be misconstrued as anti-American sentiment," Mangwana stressed.
"We welcome further dialogue with our US partners on how subsequent collaboration might be structured in a way that respects the sovereignty and interests of both nations."
Medical Community Response
A leading public health body expressed it acknowledged the official position, but suggested that negotiations must proceed since much of the nation's HIV programmes were funded by external financing.
"In cases where technical issues arise, including those involving information security or agreement terms, these can frequently be addressed through technical clarification and negotiated safeguards," the group said.
This impasse underscores the ongoing challenges between accepting vital international aid and protecting local interests in an increasingly interconnected world.